查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1696248

全球人類健康用磷蝦油市場 - 2025 至 2032 年

Global Krill Oil for Human Health Market - 2025-2032
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球人類健康磷蝦油市場價值為 2.9218 億美元，預計到 2032 年將達到 12.8168 億美元，2025 年至 2032 年期間的複合年成長率為 20.3%。

磷蝦油來自小型甲殼類動物，富含磷脂質、ω-3 脂肪酸和蝦紅素，對心血管、認知、關節和皮膚健康有顯著益處。人們對預防保健的認知不斷提高、人口老化問題日益突出以及對天然補充劑的需求正在推動市場成長。此外，臨床研究強調了磷蝦油在降低三酸甘油酯水平、發炎和促進心臟健康方面的有效性，進一步推動了其在世界範圍內的採用。

市場趨勢

預防保健和功能性營養的需求不斷成長

全球 70% 的成年人每天都會服用膳食補充劑，預防性醫療保健日益受到關注，推動了對磷蝦油的需求。哈佛醫學院和美國國立衛生研究院的研究表明，食用磷蝦油可使心臟病發作風險降低 25%，中風風險降低 20%，同時還可使高密度脂蛋白膽固醇水平提高 15%。美國婦產科醫師學會 (ACOG) 支持攝取 omega-3 來緩解 PMS 症狀，可將痙攣和情緒波動減少 40%。此外，產前保健應用也日益增多，因為 omega-3 有助於將早產風險降低 10-20%，使得磷蝦油成為產婦保健的重要補充劑。

護膚和抗衰老產品擴張

磷蝦油因其含有蝦紅素而成為護膚和抗衰老產品中的關鍵成分，蝦紅素可以對抗氧化壓力並增強皮膚水分。 2023 年 DSM 營養產品試驗發現，12 週的磷蝦油補充可使細紋減少 20%，皮膚水分增加 30%。 《美容皮膚病學雜誌》發表的研究表明，磷蝦油可以增強皮膚彈性和屏障功能，使其成為北美和歐洲美容補充劑中備受追捧的成分。挪威品牌 NYO3 推出含有膠原蛋白和玻尿酸的磷蝦油，瞄準中國女性保養品市場。

市場動態

市場促進因素：人們對心血管益處的認知不斷提高

人們對心血管健康認知的不斷提高是磷蝦油市場發展的主要動力。磷蝦油中含有的 Omega-3 脂肪酸因其在降低心臟病風險方面發揮的作用而得到了美國心臟協會 (AHA) 等組織的認可。 Mozaffarian 等人最近在 JAMA Network Open 上發表的一項研究證實，磷蝦油可以顯著降低三酸甘油酯水平，而三酸甘油酯水平是預防心臟病的關鍵標誌。此外，哈佛醫學院在 2023 年進行的研究表明，定期補充 Omega-3 可使心臟病發作的風險降低 25%，中風的風險降低 20%。

領先的磷蝦油製造商 Aker BioMarine 進行的臨床試驗表明，每日攝取磷蝦油可以降低血脂水平和血壓，進一步促進心臟健康。鑑於心血管疾病仍然是全球死亡的主要原因，越來越多的消費者開始尋求像磷蝦油這樣的天然補充劑來預防保健。政府資助的健康計畫進一步支持了這一需求，例如美國國立衛生研究院 (NIH) 的研究報告稱，使用磷蝦油的人群的 HDL（好）膽固醇水平提高了 15%。這些發現鞏固了磷蝦油在心臟健康領域改變現狀的作用，並促進了其日益普及。

市場限制：永續性議題與監管挑戰

儘管磷蝦油具有健康益處，但它市場面臨永續性和法規核准相關的挑戰。磷蝦是海洋生態系的重要組成部分，是鯨魚、海豹和企鵝等海洋生物的主要食物來源。對過度捕撈的擔憂導致了嚴格的捕撈規定，特別是在主要磷蝦油產地南極地區。南極海洋生物資源保護委員會（CCAMLR）等組織已實施配額以防止磷蝦族群枯竭，從而限制供應量的成長。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動態

  • 影響因素
    • 驅動程式
      • 人們對心血管益處的認知不斷提高
      • 永續性議題和監管挑戰
    • 限制
      • 缺乏意識
    • 機會
    • 影響分析

第5章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • 永續性分析
  • DMI 意見

第 6 章：按形式

  • 膠囊
    • 軟膠囊
    • 硬凝膠
  • 油
  • 粉末
  • 軟糖

第 7 章：按應用

  • 心血管健康
    • 改善流通
    • 心臟病和中風
    • 其他
  • 一般營養和健康
  • 女性健康
    • 經前症候群
    • 經期疼痛
    • 產前保健
    • 其他
  • 關節和骨骼健康
    • 骨關節炎
    • 骨質疏鬆症
    • 關節疼痛和炎症
    • 其他
  • 神經病學健康
    • 認知
    • 心理健康
    • 其他
  • 皮膚健康
    • 抗衰老
    • 水合和彈性
    • 其他
  • 眼睛健康
    • 乾眼症
    • 發炎
    • 其他
  • 其他

第 8 章：按銷售管道

  • B2B
  • B2C

第9章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 併購分析

第 11 章：公司簡介

  • AKER BIOMARINE
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 關鍵進展
  • Biocorp Co., Ltd.
  • Rimfrost AS
  • Shandong Kangjing Marine Biotechnology Co., Ltd

第 12 章：附錄

簡介目錄
Product Code: FB9409

Global krill oil for human health market was valued at US$ 292.18 million in 2024 and is expected to reach US$ 1,281.68 million by 2032, growing with a CAGR of 20.3% between 2025 and 2032.

Krill oil, derived from small crustaceans, is rich in phospholipids, omega-3 fatty acids, and astaxanthin, offering significant cardiovascular, cognitive, joint, and skin health benefits. Increasing awareness of preventive healthcare, aging population concerns, and demand for natural supplements is driving the market growth. Additionally, clinical studies highlighting krill oil's effectiveness in reducing triglyceride levels, inflammation, and promoting heart health have further fueled its adoption worldwide.

Market Trends

Rising Demand for Preventive Healthcare and Functional Nutrition

With 70% of adults globally consuming dietary supplements daily, preventive healthcare is gaining traction, boosting demand for krill oil. Harvard Medical School and NIH studies reveal that krill oil consumption can reduce heart attack risks by 25% and strokes by 20%, while also improving HDL cholesterol levels by 15%. The American College of Obstetricians and Gynecologists (ACOG) supports omega-3 intake for PMS symptom relief, with a 40% reduction in cramps and mood swings. Furthermore, prenatal health applications are growing, as omega-3s help reduce preterm birth risks by 10-20%, making krill oil a critical supplement for maternal care.

Expansion in Skincare and Anti-Aging Products

Krill oil is becoming a key ingredient in skincare and anti-aging products due to its astaxanthin content, which combats oxidative stress and enhances skin hydration. A 2023 DSM Nutritional Products trial found that 12 weeks of krill oil supplementation reduced fine wrinkles by 20% and improved skin hydration by 30%. Studies published in the Journal of Cosmetic Dermatology show krill oil enhances skin elasticity and barrier function, making it a sought-after ingredient in North American and European beauty supplements. Norwegian brand NYO3 is launching krill oil with collagen and hyaluronic acid, targeting the women's skincare segment in China.

Market Dynamics

Market Driver: Growing Awareness of Cardiovascular Benefits

The rising awareness of cardiovascular health is a major driver of the krill oil market. Omega-3 fatty acids found in krill oil have been endorsed by organizations like the American Heart Association (AHA) for their role in reducing heart disease risks. A recent study by Mozaffarian et al., published in JAMA Network Open, confirmed that krill oil significantly reduces triglyceride levels, a key marker for heart disease prevention. Additionally, research conducted by Harvard Medical School in 2023 demonstrated that regular omega-3 supplementation lowers the risk of heart attacks by 25% and strokes by 20%.

Clinical trials by Aker BioMarine, a leading krill oil manufacturer, highlight that daily krill oil intake reduces lipid levels and blood pressure, further supporting heart health. Given that cardiovascular diseases remain the leading cause of mortality worldwide, consumers are increasingly seeking natural supplements like krill oil for preventive care. The demand is further supported by government-funded health initiatives, such as the National Institutes of Health (NIH) study, which reported a 15% improvement in HDL (good) cholesterol levels among krill oil users. These findings solidify krill oil as a game-changer in heart health and contribute to its growing adoption.

Market Restraint: Sustainability Concerns and Regulatory Challenges

Despite its health benefits, the krill oil market faces challenges related to sustainability and regulatory approvals. Krill is a vital component of the marine ecosystem, serving as the primary food source for marine species like whales, seals, and penguins. Overfishing concerns have led to strict harvesting regulations, particularly in the Antarctic region, where the majority of krill oil is sourced. Organizations like the Commission for the Conservation of Antarctic Marine Living Resources (CCAMLR) have imposed quotas to prevent depletion of krill populations, restricting supply growth.

Segment Analysis

Capsule Form Dominates Market due to its Convenience, Extended Shelf Life

Capsules are preferred over liquid and soft gel forms because they ensure precise dosage, minimal oxidation, and higher bioavailability. Unlike fish oil, krill oil is naturally bound to phospholipids, which enhance omega-3 absorption in the body. Clinical studies indicate that krill oil capsules are 2.5 times more bioavailable than traditional fish oil capsules.

Consumer preference for on-the-go supplements is driving demand for capsule-based formulations, particularly among working professionals and the elderly. Brands like Kori Krill Oil and Aker BioMarine are launching advanced formulations, including krill oil capsules infused with turmeric, B12, and plant-based antioxidants, catering to holistic wellness needs.

Additionally, pharmaceutical and nutraceutical companies are expanding their capsule-based product portfolios to address various health concerns such as joint health, heart health, cognitive function, and skincare. The rise of e-commerce and direct-to-consumer sales channels has further accelerated the adoption of krill oil capsules, making them the fastest-growing segment in the global krill oil market.

Geographical Penetration

North America is the largest and fastest-growing market for krill oil, driven by high consumer awareness, strong demand for dietary supplements, and a growing aging population. The US and Canada account for a significant share due to their proactive health-conscious populations. According to Harvard Medical School, over 50% of U.S. adults consume omega-3 supplements, with krill oil gaining popularity over traditional fish oil due to its higher bioavailability and antioxidant content.

The American Heart Association (AHA) and the National Institutes of Health (NIH) have endorsed omega-3 fatty acids, further boosting demand. Additionally, the rising prevalence of cardiovascular diseases, which remain the leading cause of death in the U.S., has accelerated the adoption of krill oil supplements.

The North American market is also witnessing innovation in krill oil formulations. Kori Krill Oil introduced Mind & Body supplements, combining krill oil with nootropics and turmeric for cognitive and heart health. Furthermore, e-commerce channels like Amazon and Walmart are fueling online krill oil sales, making it accessible to a wider demographic. With high disposable incomes, advanced healthcare infrastructure, and strong brand presence, North America is expected to maintain its dominant position in the krill oil market.

Competitive Landscape

Segment Structure

By Form

  • Capsules
    • Softgels
    • Hardgels
  • Oil
  • Powder
  • Gummies

By Application

  • Cardiovascular Health
    • Circulation Improvement
    • Heart Attacks and Strokes
    • Others
  • General Nutrition and Wellness
  • Women Health
    • Premenstrual Syndrome
    • Period Pains
    • Prenatal Health
    • Others
  • Joint and Bone Health
    • Osteoarthritis
    • Osteoporosis
    • Join Pains and Inflammation
    • Others
  • Neurology Health
    • Cognition
    • Mental Health
    • Others
  • Skin Health
    • Anti-Aging
    • Hydration and Elasticity
    • Others
  • Eye Health
    • Dry Eye
    • Inflammation
    • Others
  • Others

By Sales Channel

  • B2B
  • B2C

By Region

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

Why Choose DataM Intelligence?

  • Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares, and value chain evaluations, enriched by interviews with industry leaders and disruptors.
  • Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
  • White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
  • Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
  • Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
  • Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Form
  • 3.2. Snippet by Application
  • 3.3. Snippet by Sales Channel
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Awareness of Cardiovascular Benefits
      • 4.1.1.2. Sustainability Concerns and Regulatory Challenges
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Awareness
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Sustainable Analysis
  • 5.6. DMI Opinion

6. By Form

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 6.1.2. Market Attractiveness Index, By Form
  • 6.2. Capsules*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Softgels
    • 6.2.4. Hardgels
  • 6.3. Oil
  • 6.4. Powder
  • 6.5. Gummies

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Cardiovascular Health*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Circulation Improvement
    • 7.2.4. Heart Attacks and Strokes
    • 7.2.5. Others
  • 7.3. General Nutrition and Wellness
  • 7.4. Women's Health
    • 7.4.1. Premenstrual Syndrome
    • 7.4.2. Period Pains
    • 7.4.3. Prenatal Health
    • 7.4.4. Others
  • 7.5. Joint and Bone Health
    • 7.5.1. Osteoarthritis
    • 7.5.2. Osteoporosis
    • 7.5.3. Join Pains and Inflammation
    • 7.5.4. Others
  • 7.6. Neurology Health
    • 7.6.1. Cognition
    • 7.6.2. Mental Health
    • 7.6.3. Others
  • 7.7. Skin Health
    • 7.7.1. Anti-Aging
    • 7.7.2. Hydration and Elasticity
    • 7.7.3. Others
  • 7.8. Eye Health
    • 7.8.1. Dry Eye
    • 7.8.2. Inflammation
    • 7.8.3. Others
  • 7.9. Others

8. By Sales Channel

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 8.1.2. Market Attractiveness Index, By Sales Channel
  • 8.2. B2B*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. B2C

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. US
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. UK
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Key Region-Specific Dynamics
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. AKER BIOMARINE*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Biocorp Co., Ltd.
  • 11.3. Rimfrost AS
  • 11.4. Shandong Kangjing Marine Biotechnology Co., Ltd

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us